163 related articles for article (PubMed ID: 21691055)
1. The use of bone age in clinical practice - part 2.
Martin DD; Wit JM; Hochberg Z; van Rijn RR; Fricke O; Werther G; Cameron N; Hertel T; Wudy SA; Butler G; Thodberg HH; Binder G; Ranke MB
Horm Res Paediatr; 2011; 76(1):10-6. PubMed ID: 21691055
[TBL] [Abstract][Full Text] [Related]
2. The use of bone age in clinical practice - part 1.
Martin DD; Wit JM; Hochberg Z; Sävendahl L; van Rijn RR; Fricke O; Cameron N; Caliebe J; Hertel T; Kiepe D; Albertsson-Wikland K; Thodberg HH; Binder G; Ranke MB
Horm Res Paediatr; 2011; 76(1):1-9. PubMed ID: 21691054
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological management of children with short stature: the role of aromatase inhibitors.
Damiani D; Damiani D
J Pediatr (Rio J); 2007 Nov; 83(5 Suppl):S172-7. PubMed ID: 17901908
[TBL] [Abstract][Full Text] [Related]
4. Pubertal disorders and bone maturation.
Lazar L; Phillip M
Endocrinol Metab Clin North Am; 2012 Dec; 41(4):805-25. PubMed ID: 23099272
[TBL] [Abstract][Full Text] [Related]
5. Aromatase Inhibitor as Treatment for Severely Advanced Bone Age in Congenital Adrenal Hyperplasia: A Case Report.
Goedegebuure WJ; Hokken-Koelega ACS
Horm Res Paediatr; 2019; 92(3):209-213. PubMed ID: 31390647
[TBL] [Abstract][Full Text] [Related]
6. Use of aromatase inhibitors in children and adolescents with disorders of growth and adolescent development.
Shulman DI; Francis GL; Palmert MR; Eugster EA;
Pediatrics; 2008 Apr; 121(4):e975-83. PubMed ID: 18381525
[TBL] [Abstract][Full Text] [Related]
7. Aromatase inhibitors in men: effects and therapeutic options.
de Ronde W; de Jong FH
Reprod Biol Endocrinol; 2011 Jun; 9():93. PubMed ID: 21693046
[TBL] [Abstract][Full Text] [Related]
8. Estrogen treatment of excessively tall girls.
Zachmann M; Ferrandez A; Můrset G; Prader A
Helv Paediatr Acta; 1975 May; 30(1):11-30. PubMed ID: 169220
[TBL] [Abstract][Full Text] [Related]
9. In boys with abnormal developmental tempo, maturation of the skeleton and the hypothalamic-pituitary-gonadal axis remains synchronous.
Flor-Cisneros A; Leschek EW; Merke DP; Barnes KM; Coco M; Cutler GB; Baron J
J Clin Endocrinol Metab; 2004 Jan; 89(1):236-41. PubMed ID: 14715856
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, placebo-controlled comparison of letrozole to oxandrolone effects upon growth and puberty of children with constitutional delay of puberty and idiopathic short stature.
Salehpour S; Alipour P; Razzaghy-Azar M; Ardeshirpour L; Shamshiri A; Monfared MF; Gharib A
Horm Res Paediatr; 2010; 74(6):428-35. PubMed ID: 20628237
[TBL] [Abstract][Full Text] [Related]
11. Aromatase inhibitors in precocious puberty: rationale and experience to date.
Eugster EA
Treat Endocrinol; 2004; 3(3):141-51. PubMed ID: 16026110
[TBL] [Abstract][Full Text] [Related]
12. Bone age progression during five years of substitutive therapy for the induction of puberty in thalassemic girls--effects on height and sitting height.
Filosa A; Di Maio S; Lamba M; Baron I; Saviano A; Esposito G
J Pediatr Endocrinol Metab; 1999; 12(4):525-30. PubMed ID: 10417968
[TBL] [Abstract][Full Text] [Related]
13. Discordant bone maturation of the hand in children with precocious puberty and congenital adrenal hyperplasia.
Vejvoda M; Grant DB
Acta Paediatr Scand; 1981 Nov; 70(6):903-5. PubMed ID: 7324944
[TBL] [Abstract][Full Text] [Related]
14. Outcome analysis of aromatase inhibitor therapy to increase adult height in males with predicted short adult stature and/or rapid pubertal progress: a retrospective chart review.
Shams K; Cameo T; Fennoy I; Hassoun AA; Lerner SE; Aranoff GS; Sopher AB; Yang C; McMahon DJ; Oberfield SE
J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):725-30. PubMed ID: 24756052
[TBL] [Abstract][Full Text] [Related]
15. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
Pasquino AM; Pucarelli I; Roggini M; Segni M
J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
[TBL] [Abstract][Full Text] [Related]
16. Growth Hormone With Aromatase Inhibitor May Improve Height in CYP11B1 Congenital Adrenal Hyperplasia.
Hawton K; Walton-Betancourth S; Rumsby G; Raine J; Dattani M
Pediatrics; 2017 Feb; 139(2):. PubMed ID: 28126912
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia.
Quintos JB; Vogiatzi MG; Harbison MD; New MI
J Clin Endocrinol Metab; 2001 Apr; 86(4):1511-7. PubMed ID: 11297576
[TBL] [Abstract][Full Text] [Related]
18. Treatment and disease effects on short-term growth and adult height in children and adolescents with 21-hydroxylase deficiency.
Hauffa BP; Winter A; Stolecke H
Klin Padiatr; 1997; 209(2):71-7. PubMed ID: 9113619
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial.
Hero M; Norjavaara E; Dunkel L
J Clin Endocrinol Metab; 2005 Dec; 90(12):6396-402. PubMed ID: 16189252
[TBL] [Abstract][Full Text] [Related]
20. Growth pattern of untreated boys with simple virilizing congenital adrenal hyperplasia indicates relative androgen insensitivity during the first six months of life.
Bonfig W; Schwarz HP
Horm Res Paediatr; 2011; 75(4):264-8. PubMed ID: 21196707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
